ADMA Biologics Investor Relations Material
Latest events
Q4 2023
ADMA Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ADMA Biologics Inc
Access all reports
ADMA Biologics, Inc. is a biotechnology company that engages in developing, manufacturing and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The Company is focused on developing therapies for patients suffering from serious diseases such as primary immunodeficiency, viral hepatitis and Crohn’s disease. ADMA Biologics Inc was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States